JHP Pharma to Produce Cardiovascular Injectable Product

JHP Pharmaceuticals has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and commercial supply of an innovative injectable used in the cardiovascular setting.
 
Stuart Hinchen, president and chief executive officer of JHP said, “We are pleased to serve this important customer and recognize that being selected to produce this injectable is based on our expertise with complex formulations coupled with our competence in both clinical supply and commercial supply. JHP’s extensive experience working with products through their life cycle starting with clinical trials through approval, product launch and global commercialization provides customers with a measure of confidence allowing them to focus on their day-to-day business priorities.”